2026 NPPES data Internal Medicine Physician NPI 1093740227 M.D
Verify on CMS →

ZULFIQAR ALI, M.D

Internal Medicine Physician in FREMONT, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 160 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
20.3349/100
▼ 63 pts below national avg 83.1 · [object Object]
Industry payments
$1.9K
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ZULFIQAR ALI, M.D reported a CMS MIPS final score of 20.3349/100 — below the 83.1 national average — and filed 3,395 Medicare Part D claims in 2023.

20.3349/100
MIPS score · -63 vs avg
3K
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ZULFIQAR ALI, M.D's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

20 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). This entry sits in this band. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ZULFIQAR ALI, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ZULFIQAR ALI, M.D?

Below national average

NPI registry status

Active

Issued 07/12/2006

NPI 1093740227

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

3,395 25% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

20.3349/100 62.76509999999999% pts

Below average band

vs 83.1 national avg

Specialty distribution in California

How Internal Medicine Physician compares to other specialties among California providers

California providers

Internal Medicine Physician share within California

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within California

Medicare quality performance — MIPS

ZULFIQAR ALI, M.D's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Below national average
MIPS Final Score
20.3349/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 20.3349/100 vs national avg 83.1

0%100%National avg83%20.3%
MIPS final score (Internal Medicine Physician) — 20.3349/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ZULFIQAR ALI, M.D is a Internal Medicine Physician provider practicing in FREMONT, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D. NPI: 1093740227. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ZULFIQAR ALI, M.D appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D credentials at 1900 MOWRY AVE, FREMONT, CA, 94538, with a listed phone of (510) 790-2422. NPI 1093740227 was issued on 07/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,395 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $284K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 2.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 20.3349/100 for the 2023 performance year (Quality 0, Cost 67.783), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1900 MOWRY AVE
FREMONT, CA 94538

Provider Details

NPI 1093740227
Specialty Internal Medicine Physician
Credentials M.D
Gender Male
NPI Issued 07/12/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

20.3349
Final Score
Avg: 83.1
0
Quality
67.783
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ZULFIQAR ALI, M.D. Source: openpaymentsdata.cms.gov.

Total received

$1.9K

Largest payer

Teva Pharmaceuticals USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ZULFIQAR ALI, M.D. To verify ZULFIQAR ALI, M.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ZULFIQAR ALI, M.D — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 3,395 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,395
Total Claims
$284K
Total Drug Cost
160
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,202
Total Day Supply
179,137
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$215K
Generic Drug Cost
$67K
Opioid Claims
95 (2.8% rate)
Antibiotic Claims
79

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.73
Gender Split
43% female / 58% male
Age Distribution
<65: 24, 65-74: 70, 75-84: 37, 85+: 29

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
202
Metoprolol Tartrate
189
Amlodipine Besylate
157
Losartan Potassium
108
Tamsulosin Hcl
100
Lisinopril
97
Clopidogrel
Clopidogrel Bisulfate
96
Metformin Hcl
95
Furosemide
77
Metoprolol Succinate
75

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How ZULFIQAR ALI, M.D fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

ZULFIQAR ALI, M.D's 3,395 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ALI.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ZULFIQAR ALI, M.D's specialty?
ZULFIQAR ALI, M.D specializes in Internal Medicine Physician and practices in FREMONT, California. Credentials: M.D.
How much does ZULFIQAR ALI, M.D prescribe under Medicare Part D?
In 2023, ZULFIQAR ALI, M.D wrote 3,395 Medicare Part D claims totaling $284K in drug costs for 160 beneficiaries.
What is ZULFIQAR ALI, M.D's Medicare quality score?
ZULFIQAR ALI, M.D has a CMS MIPS Final Score of 20.3349/100 (Quality: 0, Cost: 67.783). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ZULFIQAR ALI, M.D located?
ZULFIQAR ALI, M.D is located at 1900 MOWRY AVE, FREMONT, CA, 94538. Phone: (510) 790-2422.
What is ZULFIQAR ALI, M.D's NPI number?
ZULFIQAR ALI, M.D's National Provider Identifier (NPI) is 1093740227, issued on 07/12/2006.
Does ZULFIQAR ALI, M.D prescribe more brand-name or generic drugs?
ZULFIQAR ALI, M.D's prescribing is 12% brand-name and 88% generic drugs by claim count, with $215K in brand drug costs.
Does ZULFIQAR ALI, M.D prescribe opioids?
Yes, ZULFIQAR ALI, M.D had 95 opioid claims in 2023 with an opioid prescribing rate of 2.8%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does ZULFIQAR ALI, M.D prescribe most often?
Based on 2023 Medicare Part D data, ZULFIQAR ALI, M.D's most frequently prescribed drugs include Atorvastatin Calcium, Metoprolol Tartrate, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ZULFIQAR ALI, M.D accept Medicare?
ZULFIQAR ALI, M.D appears in CMS Medicare data with 3,395 Part D claims and 160 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ZULFIQAR ALI, M.D's credentials?
ZULFIQAR ALI, M.D's NPI is 1093740227 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology